These days we people are listening that various companies are creating sensation by getting sold for huge amounts ,especially in the fields of software and mobile applications.
In the field of Biotech ,its not that easy to get sold for huge amounts as there is a very tough competition in it. But a company did it and with in a short span of time(6 months).
Axovant,a company founded by an Indian named Vivek Ramaswamy(29) is the one which started its travel from 33 Cr and had achieved a huge amount of 20000 Cr by getting its shares sold in the public issue in the New York .
The reason for grabbing such an sensational attention is its research on developing the medicine for
Alzheimer's disease (a disease of memory loss and dementia).
Actually the famous Biotech enterprise "Glaxo Smith kine Pharmaceuticals " is the first to start research on developing the drug for Alzheimer's disease.But they stopped their research after a period. Vivek observed it and had bought the formula developed by the "Glaxo Smith kline" for 33Cr.
He further developed it and had recorded a good results in research.This made many legendary Pharmaceuticals have an attention towards Axovant.Vivek felt it would be the right time for keeping the company shares in public issue and did it.And there it is where Axovant shares were got sold at a very huge amount of approximately 19,980Cr.This all happened in a short span of six months.
Now he became billionaire and had listed in the International reputed magazine Forbes"30 under 30".Hope he would create more sensations further.
In the field of Biotech ,its not that easy to get sold for huge amounts as there is a very tough competition in it. But a company did it and with in a short span of time(6 months).
Axovant,a company founded by an Indian named Vivek Ramaswamy(29) is the one which started its travel from 33 Cr and had achieved a huge amount of 20000 Cr by getting its shares sold in the public issue in the New York .
The reason for grabbing such an sensational attention is its research on developing the medicine for
Alzheimer's disease (a disease of memory loss and dementia).
It had a notable development in their research by developing their leading drug candidate called RVT-101,recently entered MINDSET,a confirmatory phase 3 clinical study in mild-to-moderate Alzheimer's disease patients.The drug has demonstrated statistically significant benefits in cognition and function in a 684-patient phase 2b study in patients with mild-to-moderate Alzheimer's disease.They also intend to develop RVT-101 for patients with other forms of dementia
He further developed it and had recorded a good results in research.This made many legendary Pharmaceuticals have an attention towards Axovant.Vivek felt it would be the right time for keeping the company shares in public issue and did it.And there it is where Axovant shares were got sold at a very huge amount of approximately 19,980Cr.This all happened in a short span of six months.
Now he became billionaire and had listed in the International reputed magazine Forbes"30 under 30".Hope he would create more sensations further.
No comments:
Post a Comment